MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more

Profile

Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
21
Web
https://www.aimimmuno.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.62M
P/E Ratio
N/A
Total Cash
5.88M
Projected Growth
N/A
Total Debt
4.57M
Revenue
94K
Risk (Beta)
1.95
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
View a ticker or compare two or three
AIM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
21
Web
https://www.aimimmuno.com